par Baselga, José;Campone, Mario;Piccart-Gebhart, Martine ;Burris, Howard A;Rugo, Hope;Sahmoud, Tarek;Noguchi, S;Gnant, Michael;Pritchard, Kathleen;Lebrun, Fabienne;Beck, J Thaddeus;Ito, Y;Yardley, Denise A;Deleu, I;Perez, Alejandra;Bachelot, Thomas;Vittori, Luc;Xu, Z.;Mukhopadhyay, Pabak;Lebwohl, David;Hortobagyi, Gabriel N.
Référence The New England journal of medicine, 366, 6, page (520-529)
Publication Publié, 2012-02
Référence The New England journal of medicine, 366, 6, page (520-529)
Publication Publié, 2012-02
Article révisé par les pairs
Titre: |
|
Auteur: | Baselga, José; Campone, Mario; Piccart-Gebhart, Martine; Burris, Howard A; Rugo, Hope; Sahmoud, Tarek; Noguchi, S; Gnant, Michael; Pritchard, Kathleen; Lebrun, Fabienne; Beck, J Thaddeus; Ito, Y; Yardley, Denise A; Deleu, I; Perez, Alejandra; Bachelot, Thomas; Vittori, Luc; Xu, Z.; Mukhopadhyay, Pabak; Lebwohl, David; Hortobagyi, Gabriel N. |
Informations sur la publication: | The New England journal of medicine, 366, 6, page (520-529) |
Statut de publication: | Publié, 2012-02 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Androstadienes -- adverse effects -- therapeutic use | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use | |
Aromatase Inhibitors -- adverse effects -- therapeutic use | |
Bone Neoplasms -- secondary | |
Breast Neoplasms -- chemistry -- drug therapy | |
Disease-Free Survival | |
Female | |
Humans | |
Kaplan-Meier Estimate | |
Middle Aged | |
Postmenopause | |
Receptor, Epidermal Growth Factor -- analysis | |
Recurrence | |
Sirolimus -- adverse effects -- analogs & derivatives -- therapeutic use | |
Stomatitis -- chemically induced | |
TOR Serine-Threonine Kinases -- antagonists & inhibitors | |
Note générale: | Clinical Trial, Phase III |
Comparative Study | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0028-4793 |
info:doi/10.1056/NEJMoa1109653 | |
info:scp/84863078767 | |
info:pmid/22149876 |